NCT02562079View on ClinicalTrials.gov

Vasculopathy, Inflammation and Systemic Sclerosis

NACompletedINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Systemic Sclerosis
Interventions
BIOLOGICAL

Blood samples

"* biological features of the standard follow-up~* 2 more blood tube for the biological collection (serum and PBMC)"

BIOLOGICAL

Biopsy

Skin biopsies

Trial Locations (1)

33076

Service de Rhumatologie - Tripode - Hôpital Pellegrin, Bordeaux

All Listed Sponsors
collaborator

Societe Francaise de Rhumatologie

OTHER

lead

University Hospital, Bordeaux

OTHER

NCT02562079 - Vasculopathy, Inflammation and Systemic Sclerosis | Biotech Hunter | Biotech Hunter